Summary: The Centers for Medicare & Medicaid Services modified its coverage policy for supplies used in the delivery of Transcutaneous Electrical Nerve Stimulation (TENS) and Neuromuscular Electrical Stimulation (NMES), with an effective date of May 15, 2026. Here's what billing teams need to do.
This policy update touches durable medical equipment billing at the supply level — the electrodes, lead wires, and consumables your patients use at home after you dispense a TENS or NMES unit. The CMS TENS and NMES supplies coverage policy does not carry a specific policy code in the standard NCD or LCD format, but it governs reimbursement for a high-volume category that DME suppliers and outpatient practices bill regularly. No specific CPT or HCPCS codes are listed in the current policy data — we cover what that means for your workflow in the sections below.
| Field | Detail |
|---|---|
| Payer | CMS / Medicare |
| Policy | Supplies Used in the Delivery of Transcutaneous Electrical Nerve Stimulation (TENS) and Neuromuscular Electrical Stimulation (NMES) |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | 2026-05-15 |
| Impact Level | Medium-High |
| Specialties Affected | Pain management, physical therapy, orthopedic surgery, neurology, DME suppliers |
| Key Action | Audit your TENS and NMES supply billing before May 15, 2026, and confirm documentation supports medical necessity for all ongoing supply orders |
CMS TENS and NMES Supplies Coverage Criteria and Medical Necessity Requirements 2026
The Centers for Medicare & Medicaid Services governs coverage of TENS and NMES supplies under its broader framework for durable medical equipment used in the home. The coverage policy for these supplies is not a minor administrative update. It defines what Medicare will pay for, and when, at the supply level — separate from the device itself.
Medical necessity sits at the center of this policy. CMS requires that supplies be ordered in connection with a covered device, dispensed in quantities that align with the patient's documented treatment plan, and supported by a treating physician's order. If the underlying TENS or NMES device isn't covered for that patient, the supplies aren't covered either. That chain of documentation has to hold at every link.
TENS devices are primarily covered by Medicare for chronic intractable pain. The beneficiary must have a diagnosis that supports medical necessity, and the device must have demonstrated effectiveness after a trial period. NMES has a narrower footprint — Medicare covers it for muscle re-education in specific clinical contexts, including treatment of disuse atrophy where nerve supply to the muscle is intact.
Prior authorization is not routinely required for TENS and NMES supplies under current Medicare billing guidelines, but that doesn't mean you can bill without documentation. Your MAC — Medicare Administrative Contractor — sets local coverage determination rules that govern the specific diagnoses and documentation requirements in your region. Check your MAC's LCD for TENS and NMES before May 15, 2026. Policies vary by contractor, and the CMS-level modification may interact with LCD-level rules in ways that affect your claims.
The real exposure here is quantity. CMS has historically flagged TENS electrode supply billing as a target for review because suppliers over-dispense relative to what the patient's plan of care justifies. Your documentation needs to show the frequency of use and the quantity of supplies ordered, not just that a device was prescribed.
CMS TENS and NMES Exclusions and Non-Covered Indications
Medicare does not cover TENS for acute post-surgical pain beyond a limited trial period. If a patient's pain is short-term or expected to resolve, TENS supplies are not a covered benefit under this policy.
NMES for cosmetic purposes — including muscle toning without a documented clinical indication — is excluded. This isn't a gray area. Claims submitted with diagnosis codes that don't support a clinical use case will be denied.
Supplies dispensed in quantities that exceed what the patient's treatment plan documents will not be covered. This is the most common source of claim denial in this category. If your intake process isn't capturing the treating physician's documented use frequency, you're billing into a compliance risk.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Chronic intractable pain — TENS device in use | Covered | Not listed in current policy data | Medical necessity documentation required; MAC LCD applies |
| Muscle re-education / disuse atrophy — NMES device in use | Covered | Not listed in current policy data | Nerve supply to muscle must be intact; physician order required |
| Post-surgical acute pain — TENS supplies | Not Covered (beyond trial) | Not listed in current policy data | Trial period coverage varies; confirm with your MAC |
| Cosmetic muscle toning — NMES | Not Covered | Not listed in current policy data | No clinical diagnosis; claim denial expected |
| Supply quantities exceeding documented plan of care | Not Covered | Not listed in current policy data | Over-dispensing is a top audit trigger in this category |
Note: The current policy data does not list specific HCPCS or CPT codes. See the Affected Codes section below.
CMS TENS and NMES Billing Guidelines and Action Items 2026
| # | Action Item |
|---|---|
| 1 | Pull your MAC's current LCD for TENS and NMES before May 15, 2026. The CMS-level policy modification may align with or modify how your MAC interprets coverage. Don't assume the LCD you last reviewed is still current. Go to the MAC's website directly and check for any companion updates issued alongside this CMS change. |
| 2 | Audit open TENS and NMES supply orders right now. Look at every active order and confirm the underlying device is still covered, the diagnosis code supports medical necessity, and the supply quantity matches what the physician's plan of care documents. If any of those three elements are missing, correct the record before the effective date. |
| 3 | Check your HCPCS coding for TENS and NMES supplies against the most current code descriptions. The current policy data does not list specific HCPCS codes. Your DME billing team should cross-reference the supply codes you're currently using — including electrode codes and lead wire codes — against the CMS HCPCS fee schedule to confirm descriptions haven't shifted. A mismatch between the code you bill and the product you dispense is a denial waiting to happen. |
| 4 | Update your physician order template for TENS and NMES. The order should document the specific supply items, the quantity per month, the frequency of device use, and the clinical indication. "TENS supplies as needed" is not enough. CMS reviewers and MAC auditors look for specificity. If your current template doesn't capture all of that, revise it before May 15, 2026. |
| 5 | Confirm your refill process aligns with the documented plan of care. TENS and NMES supply billing for refills requires that you're not dispensing on autopilot. The patient should still be using the device, the supplies should be running low (not stockpiling), and the quantity should match what was ordered. Build a checkpoint into your DME workflow that confirms these conditions before generating a refill claim. |
| 6 | If you bill both the TENS or NMES device and the supplies, reconcile your records on both. A covered device claim and a supply claim that don't reference each other cleanly are a red flag in a post-payment audit. Your claims for supplies should trace back to the original device order without any gaps in the record. |
| 7 | Talk to your compliance officer if you have a high volume of TENS and NMES supply claims. This is not a generic caution. If TENS and NMES supplies are a material line on your revenue cycle, the May 15, 2026 effective date is a real deadline that warrants a formal internal review. Your compliance officer should know this policy changed and should sign off on your updated billing process before you submit claims under the new policy. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for TENS and NMES Supplies Under This CMS Policy
The current policy data for this CMS modification does not include a specific list of CPT, HCPCS, or ICD-10 codes. This is unusual for a supply-level DME policy and may indicate that the code-level detail lives in the MAC-level LCD rather than in the CMS parent policy.
What This Means for Your Billing Team
Do not treat the absence of listed codes as a sign that coding requirements don't apply. TENS and NMES supply billing uses HCPCS Level II codes — the specific codes for electrodes, lead wires, and related supplies. These codes are defined at the DMEPOS fee schedule level and enforced through MAC LCDs.
Your billing team should not rely on this blog post to determine which HCPCS codes to bill for a specific supply item. Pull the current DMEPOS fee schedule from CMS.gov and cross-reference with your MAC's LCD to confirm the correct codes are in your charge capture system.
Where to Find the Correct Codes
- CMS DMEPOS fee schedule: Available at CMS.gov under the Medicare fee schedule section. Updated annually.
- Your MAC's LCD for TENS: Available on your MAC's website. Search by policy topic or by device type.
- Your MAC's LCD for NMES: Listed separately from TENS in most MACs. Confirm both if you bill both device types.
We will update this post with specific HCPCS codes as soon as CMS publishes the full policy language or the MAC-level guidance is confirmed.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.